These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15053743)

  • 21. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M; Takahashi H; Shimba N; Fujii I; Shimada I
    J Mol Biol; 2007 Mar; 367(1):133-47. PubMed ID: 17239396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
    Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metal-substrate interactions facilitate the catalytic activity of the bacterial phosphotriesterase.
    Hong SB; Raushel FM
    Biochemistry; 1996 Aug; 35(33):10904-12. PubMed ID: 8718883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A general kinetic approach to investigation of active-site availability in macromolecular catalysts.
    Resmini M; Gul S; Carter S; Sonkaria S; Topham CM; Gallacher G; Brocklehurst K
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):117-25. PubMed ID: 10657247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New variation on a theme: structure and mechanism of action of hydrolytic antibody 7F11, an aspartate rich relation of catalytic antibodies 17E8 and 29G11.
    Cross SS; Brady K; Stevenson JD; Sackin JR; Kenward N; Dietel A; Thomas NR
    J Immunol Methods; 2002 Nov; 269(1-2):173-95. PubMed ID: 12379361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrolytic antibodies: variations on a theme.
    MacBeath G; Hilvert D
    Chem Biol; 1996 Jun; 3(6):433-45. PubMed ID: 8807874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement.
    Mundorff EC; Hanson MA; Varvak A; Ulrich H; Schultz PG; Stevens RC
    Biochemistry; 2000 Feb; 39(4):627-32. PubMed ID: 10651626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structural and functional basis of antibody catalysis.
    Wade H; Scanlan TS
    Annu Rev Biophys Biomol Struct; 1997; 26():461-93. PubMed ID: 9241427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pivalase catalytic antibodies: towards abzymatic activation of prodrugs.
    Bensel N; Reymond MT; Reymond JL
    Chemistry; 2001 Nov; 7(21):4604-12. PubMed ID: 11757652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution.
    Zhu X; Dickerson TJ; Rogers CJ; Kaufmann GF; Mee JM; McKenzie KM; Janda KD; Wilson IA
    Structure; 2006 Feb; 14(2):205-16. PubMed ID: 16472740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5'-Nucleotide phosphodiesterase: features of the substrate binding site as deduced from specificity and kinetics of some novel substrates.
    Landt M; Everard RA; Butler LG
    Biochemistry; 1980 Jan; 19(1):138-43. PubMed ID: 6243469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of chiral phosphate, phosphonate, and phosphinate esters by an enantioselective enzyme library.
    Nowlan C; Li Y; Hermann JC; Evans T; Carpenter J; Ghanem E; Shoichet BK; Raushel FM
    J Am Chem Soc; 2006 Dec; 128(49):15892-902. PubMed ID: 17147402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A competitive immunoassay for the detection of esterolytic activity of antibodies and enzymes.
    Benedetti F; Berti F; Flego M; Resmini M; Bastiani E
    Anal Biochem; 1998 Feb; 256(1):67-73. PubMed ID: 9466799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.